Debora Bruno, M.D., M.S., is medical director of clinical research and a thoracic medical oncologist at City of Hope® Cancer Center Atlanta. A recognized expert in her field, Dr. Bruno treats lung cancer and mesothelioma, as well as thymoma and thymic carcinoma. In other duties, she oversees City of Hope Atlanta’s clinical trials program, which investigates and develops new treatment options for patients.
Originally from Brazil, Dr. Bruno earned her medical degree from the Federal University of Ceara School of Medicine in Fortaleza, Brazil, and her master’s degree in cancer biology from MD Anderson Cancer Center in Houston, Texas. She went on to complete her first internal medicine internship at Walter Cantidio University Hospital in Fortaleza, followed by a second at Philadelphia’s Albert Einstein Medical Center. She concluded her training at Thomas Jefferson University Hospital in Philadelphia, where she completed a hematology-oncology residency and a transfusion medicine residency.
Inspired by her physician father and her experiences working with patients during medical school, Dr. Bruno is dedicated to a compassionate and respectful approach to cancer care. In the clinic, she builds a strong connection with her patients both during and after their cancer journey and collaborates with their cancer care teams to craft comprehensive and effective treatment plans that treat each patient like a person, not a diagnosis.
A respected physician-scholar, Dr. Bruno has more than 100 publications, abstract presentations and book chapters to her name, oversees dozens of clinical trials and has been recognized with multiple awards. She’s active in several professional societies and serves as a member of the National Comprehensive Cancer Network’s Clinical Practice Guidelines in Oncology Committee, which determines standards of care for non-small cell lung cancer, malignant pleural mesothelioma and thymomas and thymic carcinomas.
